Otsuka Holdings Co., Ltd. 4578.T

Healthcare · Drug Manufacturers - General · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$24.03B
Market Cap
$37.91B
Margin of Safety
-57.8%
Intrinsic / Market Ratio
0.63

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

20.62B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

26.58B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

24.88B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

24.03B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

24.03B USD

from the sum above

Market Cap

37.91B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.63×

the ratio the screener ranks by; Margin of Safety -57.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 20.62B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)18.69B USD
+②Net Cash Today1.93B USD
+③Growth Value0 USD
=Value20.62B USD

EPV of the Operations (NOPAT over WACC)

18.69B USD

Net cash today

+1.93B USD

Growth Value

0 USD

Value

20.62B USD

①EPV (earnings power value)

18.69B USD

②Net Cash Today

1.93B USD

③Growth Value

0 USD

Market value

Market Cap37.91B USD

Today's price times the shares.

Value vs market

Margin of Safety-83.9%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 26.58B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE16.57B USD
+②Equity at Year 15, Today10.01B USD
=Value26.58B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

16.57B USD

②Equity at Year 15, Today

10.01B USD

Market value

Market Cap37.91B USD

Today's price times the shares.

Value vs market

Margin of Safety-42.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 24.88B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF16.39B USD
+②Invested Capital at Year 15, Today6.56B USD
+③Net Cash Today1.93B USD
=Value24.88B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

16.39B USD

②Invested Capital at Year 15, Today

6.56B USD

③Net Cash Today

1.93B USD

Market value

Market Cap37.91B USD

Today's price times the shares.

Value vs market

Margin of Safety-52.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.52%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 651.63M USDPretax Income 3.00B USD= 21.75%

The tax the interest saves.

Interest Expense =EBIT 3.17B USD−Pretax Income 3.00B USD= 173.00M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 173.00M USDTotal Debt 1.20B USD×(1 − Tax Rate for WACC 21.75%)= 11.28%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.20B USDMarket Cap + Total Debt 37.91B USD + 1.20B USD= 3.07%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 96.93%×Cost of Equity 10.50%+Debt Weight 3.07%×Cost of Debt 11.28%= 10.52%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 27.18B USD − Total Liabilities 6.73B USD = Book Value Today 20.44B USD

Total Debt 1.20B USD − Cash and Short-Term Investments 3.13B USD = Net Debt Today -1.93B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.2%at most 5%passes525,393,423 / 542,686,037
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets1.0%at least -10.0%passes(2.58B USD − 2.32B USD) ÷ 27.18B USD
Price to bookMarket Cap ÷ Book Value Today1.85×at most 3×passes37.91B USD ÷ 20.44B USD
Operating marginOperating Income ÷ Revenue19.1%above 10.0%passes3.02B USD ÷ 15.80B USD
Revenue growthRevenue ÷ Revenue a Year Before − 16.4%above 10.0%does not pass15.80B USD / 14.86B USD
Net cash(Cash − Total Debt) ÷ Market Cap4.5%above -30%passes(2.90B USD − 1.20B USD) ÷ 37.91B USD
Operating efficiencyOperating Income ÷ Gross Profit26.7%above 25.0%passes3.02B USD ÷ 11.33B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

11.33K USD

Enterprise value

5.74T USD

market cap plus net debt

EV / EBITDA

9.88×

Price / book

1.84×

the provider's book

Price / earnings

14.74×

Return on equity

13.4%

the provider's, not the engine's

Profit margin

15.5%

Revenue growth

17.4%

Analyst target, mean

14.95K USD

Analysts

12

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

13.09B14.29B14.86B15.80B

Gross profit

8.80B9.96B10.64B11.33B

Operating income

1.40B2.06B2.65B3.02B

EBITDA

operating income before depreciation and amortisation

2.05B1.75B2.89B3.91B

Pretax income

1.30B1.01B2.14B3.00B

Net income

1.01B860.76M2.19B2.32B

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

1.26B1.93B2.80B2.46B

R&D

2.07B2.18B2.00B2.26B
Balance sheet, year end

Total assets

23.37B23.79B23.84B26.86B

Total liabilities

6.33B6.55B6.13B7.03B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

16.76B16.94B17.43B19.41B

Total debt

1.46B1.52B1.21B1.46B

Cash and equivalents

3.55B3.63B2.72B3.42B

Net PP&E

fixed assets after depreciation

3.85B3.92B4.01B4.46B

Working capital

current assets less current liabilities

4.92B4.67B4.68B5.59B
Cash flow

Operating cash flow

1.60B2.00B2.26B2.58B

Capital expenditure

paid out, so below zero

-811.75M-811.62M-824.81M-906.64M

Depreciation and amortisation

706.12M692.04M688.47M743.44M

Free cash flow

operating cash flow plus capital expenditure

783.69M1.19B1.44B1.68B